IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway. - Wikidata - wikimedia - TriplyDB

IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.

IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.

http://www.wikidata.org/entity/Q33757703

about

Mesenchymal stem cells as delivery vectors for anti-tumor therapy International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

P2860

Q26861201-AB1C820B-0ADD-43E7-93B4-7409FC55E70F Q30488740-E0CAF3B3-BC8A-407B-87C2-0C1268B8107B Q36453386-63F8D230-4BC2-459D-BF03-7CB9A3E35D99 Q42391294-B353110F-2FB2-42B4-8652-644678EBB614 Q50058491-CB26A934-A12F-40BD-B7CE-70301E7D0938 Q52608756-01616F7B-3633-4095-A82E-C0A640CB8141 Q55065461-B697C7A6-0F9C-4140-953D-049588113380

P2860

IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.

http://www.wikidata.org/entity/Q33757703

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@ast

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@en

type

label

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@ast

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@en

prefLabel

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@ast

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@en

P1433

Q33757703-AC797305-4954-4BD3-9DFE-3A5F4CCC654B

P1476

Q33757703-AA7C4798-4E2F-477A-8B78-708DA18D22BD

P2093

Q33757703-42C0F59F-9D96-4FAE-92F7-27DCCB1E385F

Q33757703-5FD29AC2-CC3D-4BD6-AB70-A53435C0D439

Q33757703-75935FD2-2D9B-4404-A3D8-8D0BBDB6216F

Q33757703-B2EBBEBE-967E-449B-A243-54BFC5B18580

Q33757703-B89AB770-3FED-4255-9317-88C396060677

P2860

Q33757703-1D03EE8E-478D-4635-A2CD-5D489F6756F2

Q33757703-3D653550-49D5-45F4-8124-643F48241610

Q33757703-445C448E-D10D-4554-AAE7-53D106C4D111

Q33757703-4C75DD21-25E1-439C-9739-CCEF0029600A

Q33757703-503D0CCB-FE7E-4E75-87AD-CDB84561B56E

Q33757703-67A52A9B-DBA7-4603-8211-4FF6F4718471

Q33757703-69B2DF0A-C1D9-4EB8-AEE6-B2CC9598B8F2

Q33757703-798DB84C-F9DE-40CE-8A63-5292E936BEDE

Q33757703-7B440877-D230-4F6E-80C1-A98C5BFCCD52

Q33757703-8743AB56-2B04-4A6B-9815-054438486C91

P304

Q33757703-598347A7-7A56-42A2-97D0-AB9B455233D6

P31

Q33757703-364305B8-ABB4-4226-B3D4-9BBD42FB80C2

P356

Q33757703-7AC1909C-877B-4EB4-8E9F-A6DA5B7E6A23

P478

Q33757703-A176720A-AECD-4765-B1EF-799650183977

P577

Q33757703-ABE9AFBF-9303-4C92-96D9-2A2E825C8E3E

P5875

Q33757703-09246D66-A15B-4774-B449-42F967F036D4

P698

Q33757703-E511905D-2BA6-4554-98C5-AFE6D5FA3A29

P932

Q33757703-F3E8AB42-2AB7-4250-8803-5569B212A1AD

P356

P1433

Journal of Immunology Research

P1476

IFN-γ-secreting-mesenchymal st ...... in vivo via the TRAIL pathway.

@en

P2093

Chun Xu

http://www.w3.org/2001/XMLSchema#string

Jingchun Du

http://www.w3.org/2001/XMLSchema#string

Wu Song

http://www.w3.org/2001/XMLSchema#string

Xia Xu

http://www.w3.org/2001/XMLSchema#string

Xinyuan Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma

Multilineage potential of adult human mesenchymal stem cells

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.

Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.

The molecular genetics of lentiviral vectors--current and future perspectives.

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.

P304

318098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/318098

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263515751

http://www.w3.org/2001/XMLSchema#string

P698

24971369

http://www.w3.org/2001/XMLSchema#string

P932

4058226

http://www.w3.org/2001/XMLSchema#string